Biora Therapeutics(BIOR) - 2023 Q4 - Annual Results

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood SAN DIEGO, March 26, 2024 – Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2023. Exhibit 99.1 All performance target ...